Phoenix Bio

論文一覧

論文一覧

EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy.

2011/05/01

    Lupberger J, Zeisel MB, Xiao F, Thumann C, Fofana I, Zona L, Davis C, Mee CJ, Turek M, Gorke S, Royer C, Fischer B, Zahid MN, Lavillette D, Fresquet J, Cosset FL, Rothenberg SM, Pietschmann T, Patel AH, Pessaux P, Doffoël M, Raffelsberger W, Poch O, McKea
    Nat Med. 2011 May;17(5):589-95.